Moderna Inc (NAS:MRNA)
$ 141.01 8.11 (6.1%) Market Cap: 54.04 Bil Enterprise Value: 43.65 Bil PE Ratio: 0 PB Ratio: 4.21 GF Score: 68/100

Moderna Inc at Sanford C Bernstein Operational Decisions Conference Transcript

Nov 04, 2021 / 08:30PM GMT
Release Date Price: $284.02 (-17.89%)
Unidentified Analyst

Hi, everybody, and thank you for joining us in the end of earnings day to actually participate in this conference call with Stephane Bancel, the CEO of Moderna. We'll try to cover 4 topics today a little bit by the logic of durability of the business of COVID-19 vaccines, the challenge of multivalent vaccines, curing additional diseases beyond immunogenicity, and a little bit about the experience of being a CEO of the company that attempts to change the world by -- while growing up at the same time. So Stephane, thank you very much for joining us today.

Stephane Bancel
Moderna, Inc. - CEO & Director

Thank you for having me.

Questions & Answers

Unidentified Analyst

So let's start with a discussion of the logic of boosting long term. So I think at this point, we kind of realize there is a logic to boost people once after getting the 2 initial shots. The question is the logic and evidence for the need for boosting every year.

There seems to be some debate that we will be building

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot